Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,795.90
-59.60 (-3.21%)
Oct 23, 2026, 12:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 291.82 billion as of October 22, 2026. It is the 4,911th most valuable company in the world and the 276th biggest in India. Its market cap has increased by 30.83% in one year.
Market Cap
291.82B
Enterprise Value
311.42B
Revenue
36.53B
Global Rank
Country Rank
#276 India
PE Ratio
71.30
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 291.82B, an increase of 1,576.76%. That is a compound annual growth rate of 11.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 291.82B | 24.18% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 623.72B |
| Alkem Laboratories | 598.30B |
| Gland Pharma | 498.17B |
| Ipca Laboratories | 460.35B |
| Ajanta Pharma | 412.15B |
| Emcure Pharmaceuticals | 335.09B |
| Piramal Pharma | 258.46B |
| Cohance Lifesciences | 175.11B |